Medical Care
Global Biologics CDMO Services Market Research Report 2025
- Sep 24, 25
- ID: 519994
- Pages: 92
- Figures: 94
- Views: 5
This report aims to provide a comprehensive presentation of the global market for Biologics CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics CDMO Services.
The Biologics CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biologics CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
WuXi Biologics
Recipharm
Thermo Fisher Scientific
AGC Biologics
Rentschler Biopharma
KBI Biopharma
Siegfried
Aenova Group
GenScript
ProBioGen
Northway Biotech
3P Biopharmaceuticals
Segment by Type
Cell and Gene Therapies
Antibodies
Vaccines
Other
Segment by Application
SMBs
Large Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Biologics CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biologics CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
WuXi Biologics
Recipharm
Thermo Fisher Scientific
AGC Biologics
Rentschler Biopharma
KBI Biopharma
Siegfried
Aenova Group
GenScript
ProBioGen
Northway Biotech
3P Biopharmaceuticals
Segment by Type
Cell and Gene Therapies
Antibodies
Vaccines
Other
Segment by Application
SMBs
Large Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics CDMO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cell and Gene Therapies
1.2.3 Antibodies
1.2.4 Vaccines
1.2.5 Other
1.3 Market by Application
1.3.1 Global Biologics CDMO Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 SMBs
1.3.3 Large Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics CDMO Services Market Perspective (2020-2031)
2.2 Global Biologics CDMO Services Growth Trends by Region
2.2.1 Global Biologics CDMO Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biologics CDMO Services Historic Market Size by Region (2020-2025)
2.2.3 Biologics CDMO Services Forecasted Market Size by Region (2026-2031)
2.3 Biologics CDMO Services Market Dynamics
2.3.1 Biologics CDMO Services Industry Trends
2.3.2 Biologics CDMO Services Market Drivers
2.3.3 Biologics CDMO Services Market Challenges
2.3.4 Biologics CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics CDMO Services Players by Revenue
3.1.1 Global Top Biologics CDMO Services Players by Revenue (2020-2025)
3.1.2 Global Biologics CDMO Services Revenue Market Share by Players (2020-2025)
3.2 Global Biologics CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biologics CDMO Services Revenue
3.4 Global Biologics CDMO Services Market Concentration Ratio
3.4.1 Global Biologics CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics CDMO Services Revenue in 2024
3.5 Global Key Players of Biologics CDMO Services Head office and Area Served
3.6 Global Key Players of Biologics CDMO Services, Product and Application
3.7 Global Key Players of Biologics CDMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics CDMO Services Breakdown Data by Type
4.1 Global Biologics CDMO Services Historic Market Size by Type (2020-2025)
4.2 Global Biologics CDMO Services Forecasted Market Size by Type (2026-2031)
5 Biologics CDMO Services Breakdown Data by Application
5.1 Global Biologics CDMO Services Historic Market Size by Application (2020-2025)
5.2 Global Biologics CDMO Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biologics CDMO Services Market Size (2020-2031)
6.2 North America Biologics CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biologics CDMO Services Market Size by Country (2020-2025)
6.4 North America Biologics CDMO Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics CDMO Services Market Size (2020-2031)
7.2 Europe Biologics CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biologics CDMO Services Market Size by Country (2020-2025)
7.4 Europe Biologics CDMO Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics CDMO Services Market Size (2020-2031)
8.2 Asia-Pacific Biologics CDMO Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biologics CDMO Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Biologics CDMO Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics CDMO Services Market Size (2020-2031)
9.2 Latin America Biologics CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biologics CDMO Services Market Size by Country (2020-2025)
9.4 Latin America Biologics CDMO Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics CDMO Services Market Size (2020-2031)
10.2 Middle East & Africa Biologics CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biologics CDMO Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Biologics CDMO Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Biologics CDMO Services Introduction
11.1.4 Lonza Revenue in Biologics CDMO Services Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Details
11.2.2 Catalent Business Overview
11.2.3 Catalent Biologics CDMO Services Introduction
11.2.4 Catalent Revenue in Biologics CDMO Services Business (2020-2025)
11.2.5 Catalent Recent Development
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Details
11.3.2 Samsung Biologics Business Overview
11.3.3 Samsung Biologics Biologics CDMO Services Introduction
11.3.4 Samsung Biologics Revenue in Biologics CDMO Services Business (2020-2025)
11.3.5 Samsung Biologics Recent Development
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Details
11.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.4.3 FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Introduction
11.4.4 FUJIFILM Diosynth Biotechnologies Revenue in Biologics CDMO Services Business (2020-2025)
11.4.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Biologics CDMO Services Introduction
11.5.4 Boehringer Ingelheim Revenue in Biologics CDMO Services Business (2020-2025)
11.5.5 Boehringer Ingelheim Recent Development
11.6 WuXi Biologics
11.6.1 WuXi Biologics Company Details
11.6.2 WuXi Biologics Business Overview
11.6.3 WuXi Biologics Biologics CDMO Services Introduction
11.6.4 WuXi Biologics Revenue in Biologics CDMO Services Business (2020-2025)
11.6.5 WuXi Biologics Recent Development
11.7 Recipharm
11.7.1 Recipharm Company Details
11.7.2 Recipharm Business Overview
11.7.3 Recipharm Biologics CDMO Services Introduction
11.7.4 Recipharm Revenue in Biologics CDMO Services Business (2020-2025)
11.7.5 Recipharm Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Biologics CDMO Services Introduction
11.8.4 Thermo Fisher Scientific Revenue in Biologics CDMO Services Business (2020-2025)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 AGC Biologics
11.9.1 AGC Biologics Company Details
11.9.2 AGC Biologics Business Overview
11.9.3 AGC Biologics Biologics CDMO Services Introduction
11.9.4 AGC Biologics Revenue in Biologics CDMO Services Business (2020-2025)
11.9.5 AGC Biologics Recent Development
11.10 Rentschler Biopharma
11.10.1 Rentschler Biopharma Company Details
11.10.2 Rentschler Biopharma Business Overview
11.10.3 Rentschler Biopharma Biologics CDMO Services Introduction
11.10.4 Rentschler Biopharma Revenue in Biologics CDMO Services Business (2020-2025)
11.10.5 Rentschler Biopharma Recent Development
11.11 KBI Biopharma
11.11.1 KBI Biopharma Company Details
11.11.2 KBI Biopharma Business Overview
11.11.3 KBI Biopharma Biologics CDMO Services Introduction
11.11.4 KBI Biopharma Revenue in Biologics CDMO Services Business (2020-2025)
11.11.5 KBI Biopharma Recent Development
11.12 Siegfried
11.12.1 Siegfried Company Details
11.12.2 Siegfried Business Overview
11.12.3 Siegfried Biologics CDMO Services Introduction
11.12.4 Siegfried Revenue in Biologics CDMO Services Business (2020-2025)
11.12.5 Siegfried Recent Development
11.13 Aenova Group
11.13.1 Aenova Group Company Details
11.13.2 Aenova Group Business Overview
11.13.3 Aenova Group Biologics CDMO Services Introduction
11.13.4 Aenova Group Revenue in Biologics CDMO Services Business (2020-2025)
11.13.5 Aenova Group Recent Development
11.14 GenScript
11.14.1 GenScript Company Details
11.14.2 GenScript Business Overview
11.14.3 GenScript Biologics CDMO Services Introduction
11.14.4 GenScript Revenue in Biologics CDMO Services Business (2020-2025)
11.14.5 GenScript Recent Development
11.15 ProBioGen
11.15.1 ProBioGen Company Details
11.15.2 ProBioGen Business Overview
11.15.3 ProBioGen Biologics CDMO Services Introduction
11.15.4 ProBioGen Revenue in Biologics CDMO Services Business (2020-2025)
11.15.5 ProBioGen Recent Development
11.16 Northway Biotech
11.16.1 Northway Biotech Company Details
11.16.2 Northway Biotech Business Overview
11.16.3 Northway Biotech Biologics CDMO Services Introduction
11.16.4 Northway Biotech Revenue in Biologics CDMO Services Business (2020-2025)
11.16.5 Northway Biotech Recent Development
11.17 3P Biopharmaceuticals
11.17.1 3P Biopharmaceuticals Company Details
11.17.2 3P Biopharmaceuticals Business Overview
11.17.3 3P Biopharmaceuticals Biologics CDMO Services Introduction
11.17.4 3P Biopharmaceuticals Revenue in Biologics CDMO Services Business (2020-2025)
11.17.5 3P Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics CDMO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cell and Gene Therapies
1.2.3 Antibodies
1.2.4 Vaccines
1.2.5 Other
1.3 Market by Application
1.3.1 Global Biologics CDMO Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 SMBs
1.3.3 Large Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics CDMO Services Market Perspective (2020-2031)
2.2 Global Biologics CDMO Services Growth Trends by Region
2.2.1 Global Biologics CDMO Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biologics CDMO Services Historic Market Size by Region (2020-2025)
2.2.3 Biologics CDMO Services Forecasted Market Size by Region (2026-2031)
2.3 Biologics CDMO Services Market Dynamics
2.3.1 Biologics CDMO Services Industry Trends
2.3.2 Biologics CDMO Services Market Drivers
2.3.3 Biologics CDMO Services Market Challenges
2.3.4 Biologics CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics CDMO Services Players by Revenue
3.1.1 Global Top Biologics CDMO Services Players by Revenue (2020-2025)
3.1.2 Global Biologics CDMO Services Revenue Market Share by Players (2020-2025)
3.2 Global Biologics CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biologics CDMO Services Revenue
3.4 Global Biologics CDMO Services Market Concentration Ratio
3.4.1 Global Biologics CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics CDMO Services Revenue in 2024
3.5 Global Key Players of Biologics CDMO Services Head office and Area Served
3.6 Global Key Players of Biologics CDMO Services, Product and Application
3.7 Global Key Players of Biologics CDMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics CDMO Services Breakdown Data by Type
4.1 Global Biologics CDMO Services Historic Market Size by Type (2020-2025)
4.2 Global Biologics CDMO Services Forecasted Market Size by Type (2026-2031)
5 Biologics CDMO Services Breakdown Data by Application
5.1 Global Biologics CDMO Services Historic Market Size by Application (2020-2025)
5.2 Global Biologics CDMO Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biologics CDMO Services Market Size (2020-2031)
6.2 North America Biologics CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biologics CDMO Services Market Size by Country (2020-2025)
6.4 North America Biologics CDMO Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics CDMO Services Market Size (2020-2031)
7.2 Europe Biologics CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biologics CDMO Services Market Size by Country (2020-2025)
7.4 Europe Biologics CDMO Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics CDMO Services Market Size (2020-2031)
8.2 Asia-Pacific Biologics CDMO Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biologics CDMO Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Biologics CDMO Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics CDMO Services Market Size (2020-2031)
9.2 Latin America Biologics CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biologics CDMO Services Market Size by Country (2020-2025)
9.4 Latin America Biologics CDMO Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics CDMO Services Market Size (2020-2031)
10.2 Middle East & Africa Biologics CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biologics CDMO Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Biologics CDMO Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Biologics CDMO Services Introduction
11.1.4 Lonza Revenue in Biologics CDMO Services Business (2020-2025)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Details
11.2.2 Catalent Business Overview
11.2.3 Catalent Biologics CDMO Services Introduction
11.2.4 Catalent Revenue in Biologics CDMO Services Business (2020-2025)
11.2.5 Catalent Recent Development
11.3 Samsung Biologics
11.3.1 Samsung Biologics Company Details
11.3.2 Samsung Biologics Business Overview
11.3.3 Samsung Biologics Biologics CDMO Services Introduction
11.3.4 Samsung Biologics Revenue in Biologics CDMO Services Business (2020-2025)
11.3.5 Samsung Biologics Recent Development
11.4 FUJIFILM Diosynth Biotechnologies
11.4.1 FUJIFILM Diosynth Biotechnologies Company Details
11.4.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.4.3 FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Introduction
11.4.4 FUJIFILM Diosynth Biotechnologies Revenue in Biologics CDMO Services Business (2020-2025)
11.4.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Biologics CDMO Services Introduction
11.5.4 Boehringer Ingelheim Revenue in Biologics CDMO Services Business (2020-2025)
11.5.5 Boehringer Ingelheim Recent Development
11.6 WuXi Biologics
11.6.1 WuXi Biologics Company Details
11.6.2 WuXi Biologics Business Overview
11.6.3 WuXi Biologics Biologics CDMO Services Introduction
11.6.4 WuXi Biologics Revenue in Biologics CDMO Services Business (2020-2025)
11.6.5 WuXi Biologics Recent Development
11.7 Recipharm
11.7.1 Recipharm Company Details
11.7.2 Recipharm Business Overview
11.7.3 Recipharm Biologics CDMO Services Introduction
11.7.4 Recipharm Revenue in Biologics CDMO Services Business (2020-2025)
11.7.5 Recipharm Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Biologics CDMO Services Introduction
11.8.4 Thermo Fisher Scientific Revenue in Biologics CDMO Services Business (2020-2025)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 AGC Biologics
11.9.1 AGC Biologics Company Details
11.9.2 AGC Biologics Business Overview
11.9.3 AGC Biologics Biologics CDMO Services Introduction
11.9.4 AGC Biologics Revenue in Biologics CDMO Services Business (2020-2025)
11.9.5 AGC Biologics Recent Development
11.10 Rentschler Biopharma
11.10.1 Rentschler Biopharma Company Details
11.10.2 Rentschler Biopharma Business Overview
11.10.3 Rentschler Biopharma Biologics CDMO Services Introduction
11.10.4 Rentschler Biopharma Revenue in Biologics CDMO Services Business (2020-2025)
11.10.5 Rentschler Biopharma Recent Development
11.11 KBI Biopharma
11.11.1 KBI Biopharma Company Details
11.11.2 KBI Biopharma Business Overview
11.11.3 KBI Biopharma Biologics CDMO Services Introduction
11.11.4 KBI Biopharma Revenue in Biologics CDMO Services Business (2020-2025)
11.11.5 KBI Biopharma Recent Development
11.12 Siegfried
11.12.1 Siegfried Company Details
11.12.2 Siegfried Business Overview
11.12.3 Siegfried Biologics CDMO Services Introduction
11.12.4 Siegfried Revenue in Biologics CDMO Services Business (2020-2025)
11.12.5 Siegfried Recent Development
11.13 Aenova Group
11.13.1 Aenova Group Company Details
11.13.2 Aenova Group Business Overview
11.13.3 Aenova Group Biologics CDMO Services Introduction
11.13.4 Aenova Group Revenue in Biologics CDMO Services Business (2020-2025)
11.13.5 Aenova Group Recent Development
11.14 GenScript
11.14.1 GenScript Company Details
11.14.2 GenScript Business Overview
11.14.3 GenScript Biologics CDMO Services Introduction
11.14.4 GenScript Revenue in Biologics CDMO Services Business (2020-2025)
11.14.5 GenScript Recent Development
11.15 ProBioGen
11.15.1 ProBioGen Company Details
11.15.2 ProBioGen Business Overview
11.15.3 ProBioGen Biologics CDMO Services Introduction
11.15.4 ProBioGen Revenue in Biologics CDMO Services Business (2020-2025)
11.15.5 ProBioGen Recent Development
11.16 Northway Biotech
11.16.1 Northway Biotech Company Details
11.16.2 Northway Biotech Business Overview
11.16.3 Northway Biotech Biologics CDMO Services Introduction
11.16.4 Northway Biotech Revenue in Biologics CDMO Services Business (2020-2025)
11.16.5 Northway Biotech Recent Development
11.17 3P Biopharmaceuticals
11.17.1 3P Biopharmaceuticals Company Details
11.17.2 3P Biopharmaceuticals Business Overview
11.17.3 3P Biopharmaceuticals Biologics CDMO Services Introduction
11.17.4 3P Biopharmaceuticals Revenue in Biologics CDMO Services Business (2020-2025)
11.17.5 3P Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biologics CDMO Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cell and Gene Therapies
Table 3. Key Players of Antibodies
Table 4. Key Players of Vaccines
Table 5. Key Players of Other
Table 6. Global Biologics CDMO Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biologics CDMO Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Biologics CDMO Services Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Biologics CDMO Services Market Share by Region (2020-2025)
Table 10. Global Biologics CDMO Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Biologics CDMO Services Market Share by Region (2026-2031)
Table 12. Biologics CDMO Services Market Trends
Table 13. Biologics CDMO Services Market Drivers
Table 14. Biologics CDMO Services Market Challenges
Table 15. Biologics CDMO Services Market Restraints
Table 16. Global Biologics CDMO Services Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Biologics CDMO Services Market Share by Players (2020-2025)
Table 18. Global Top Biologics CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics CDMO Services as of 2024)
Table 19. Ranking of Global Top Biologics CDMO Services Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Biologics CDMO Services Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Biologics CDMO Services, Headquarters and Area Served
Table 22. Global Key Players of Biologics CDMO Services, Product and Application
Table 23. Global Key Players of Biologics CDMO Services, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biologics CDMO Services Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Biologics CDMO Services Revenue Market Share by Type (2020-2025)
Table 27. Global Biologics CDMO Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Biologics CDMO Services Revenue Market Share by Type (2026-2031)
Table 29. Global Biologics CDMO Services Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Biologics CDMO Services Revenue Market Share by Application (2020-2025)
Table 31. Global Biologics CDMO Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Biologics CDMO Services Revenue Market Share by Application (2026-2031)
Table 33. North America Biologics CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Biologics CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Biologics CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Biologics CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Biologics CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Biologics CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Biologics CDMO Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Biologics CDMO Services Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Biologics CDMO Services Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Biologics CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Biologics CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biologics CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Biologics CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Biologics CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Biologics CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 48. Lonza Company Details
Table 49. Lonza Business Overview
Table 50. Lonza Biologics CDMO Services Product
Table 51. Lonza Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 52. Lonza Recent Development
Table 53. Catalent Company Details
Table 54. Catalent Business Overview
Table 55. Catalent Biologics CDMO Services Product
Table 56. Catalent Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 57. Catalent Recent Development
Table 58. Samsung Biologics Company Details
Table 59. Samsung Biologics Business Overview
Table 60. Samsung Biologics Biologics CDMO Services Product
Table 61. Samsung Biologics Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 62. Samsung Biologics Recent Development
Table 63. FUJIFILM Diosynth Biotechnologies Company Details
Table 64. FUJIFILM Diosynth Biotechnologies Business Overview
Table 65. FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Product
Table 66. FUJIFILM Diosynth Biotechnologies Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 67. FUJIFILM Diosynth Biotechnologies Recent Development
Table 68. Boehringer Ingelheim Company Details
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Biologics CDMO Services Product
Table 71. Boehringer Ingelheim Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 72. Boehringer Ingelheim Recent Development
Table 73. WuXi Biologics Company Details
Table 74. WuXi Biologics Business Overview
Table 75. WuXi Biologics Biologics CDMO Services Product
Table 76. WuXi Biologics Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 77. WuXi Biologics Recent Development
Table 78. Recipharm Company Details
Table 79. Recipharm Business Overview
Table 80. Recipharm Biologics CDMO Services Product
Table 81. Recipharm Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 82. Recipharm Recent Development
Table 83. Thermo Fisher Scientific Company Details
Table 84. Thermo Fisher Scientific Business Overview
Table 85. Thermo Fisher Scientific Biologics CDMO Services Product
Table 86. Thermo Fisher Scientific Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 87. Thermo Fisher Scientific Recent Development
Table 88. AGC Biologics Company Details
Table 89. AGC Biologics Business Overview
Table 90. AGC Biologics Biologics CDMO Services Product
Table 91. AGC Biologics Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 92. AGC Biologics Recent Development
Table 93. Rentschler Biopharma Company Details
Table 94. Rentschler Biopharma Business Overview
Table 95. Rentschler Biopharma Biologics CDMO Services Product
Table 96. Rentschler Biopharma Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 97. Rentschler Biopharma Recent Development
Table 98. KBI Biopharma Company Details
Table 99. KBI Biopharma Business Overview
Table 100. KBI Biopharma Biologics CDMO Services Product
Table 101. KBI Biopharma Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 102. KBI Biopharma Recent Development
Table 103. Siegfried Company Details
Table 104. Siegfried Business Overview
Table 105. Siegfried Biologics CDMO Services Product
Table 106. Siegfried Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 107. Siegfried Recent Development
Table 108. Aenova Group Company Details
Table 109. Aenova Group Business Overview
Table 110. Aenova Group Biologics CDMO Services Product
Table 111. Aenova Group Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 112. Aenova Group Recent Development
Table 113. GenScript Company Details
Table 114. GenScript Business Overview
Table 115. GenScript Biologics CDMO Services Product
Table 116. GenScript Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 117. GenScript Recent Development
Table 118. ProBioGen Company Details
Table 119. ProBioGen Business Overview
Table 120. ProBioGen Biologics CDMO Services Product
Table 121. ProBioGen Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 122. ProBioGen Recent Development
Table 123. Northway Biotech Company Details
Table 124. Northway Biotech Business Overview
Table 125. Northway Biotech Biologics CDMO Services Product
Table 126. Northway Biotech Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 127. Northway Biotech Recent Development
Table 128. 3P Biopharmaceuticals Company Details
Table 129. 3P Biopharmaceuticals Business Overview
Table 130. 3P Biopharmaceuticals Biologics CDMO Services Product
Table 131. 3P Biopharmaceuticals Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 132. 3P Biopharmaceuticals Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Biologics CDMO Services Picture
Figure 2. Global Biologics CDMO Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biologics CDMO Services Market Share by Type: 2024 VS 2031
Figure 4. Cell and Gene Therapies Features
Figure 5. Antibodies Features
Figure 6. Vaccines Features
Figure 7. Other Features
Figure 8. Global Biologics CDMO Services Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Biologics CDMO Services Market Share by Application: 2024 VS 2031
Figure 10. SMBs Case Studies
Figure 11. Large Companies Case Studies
Figure 12. Biologics CDMO Services Report Years Considered
Figure 13. Global Biologics CDMO Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Biologics CDMO Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Biologics CDMO Services Market Share by Region: 2024 VS 2031
Figure 16. Global Biologics CDMO Services Market Share by Players in 2024
Figure 17. Global Top Biologics CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics CDMO Services as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Biologics CDMO Services Revenue in 2024
Figure 19. North America Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Biologics CDMO Services Market Share by Country (2020-2031)
Figure 21. United States Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Biologics CDMO Services Market Share by Country (2020-2031)
Figure 25. Germany Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Biologics CDMO Services Market Share by Region (2020-2031)
Figure 33. China Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Biologics CDMO Services Market Share by Country (2020-2031)
Figure 41. Mexico Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Biologics CDMO Services Market Share by Country (2020-2031)
Figure 45. Turkey Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Lonza Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 49. Catalent Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 50. Samsung Biologics Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 51. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 52. Boehringer Ingelheim Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 53. WuXi Biologics Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 54. Recipharm Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 56. AGC Biologics Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 57. Rentschler Biopharma Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 58. KBI Biopharma Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 59. Siegfried Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 60. Aenova Group Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 61. GenScript Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 62. ProBioGen Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 63. Northway Biotech Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 64. 3P Biopharmaceuticals Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Biologics CDMO Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cell and Gene Therapies
Table 3. Key Players of Antibodies
Table 4. Key Players of Vaccines
Table 5. Key Players of Other
Table 6. Global Biologics CDMO Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biologics CDMO Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Biologics CDMO Services Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Biologics CDMO Services Market Share by Region (2020-2025)
Table 10. Global Biologics CDMO Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Biologics CDMO Services Market Share by Region (2026-2031)
Table 12. Biologics CDMO Services Market Trends
Table 13. Biologics CDMO Services Market Drivers
Table 14. Biologics CDMO Services Market Challenges
Table 15. Biologics CDMO Services Market Restraints
Table 16. Global Biologics CDMO Services Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Biologics CDMO Services Market Share by Players (2020-2025)
Table 18. Global Top Biologics CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics CDMO Services as of 2024)
Table 19. Ranking of Global Top Biologics CDMO Services Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Biologics CDMO Services Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Biologics CDMO Services, Headquarters and Area Served
Table 22. Global Key Players of Biologics CDMO Services, Product and Application
Table 23. Global Key Players of Biologics CDMO Services, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biologics CDMO Services Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Biologics CDMO Services Revenue Market Share by Type (2020-2025)
Table 27. Global Biologics CDMO Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Biologics CDMO Services Revenue Market Share by Type (2026-2031)
Table 29. Global Biologics CDMO Services Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Biologics CDMO Services Revenue Market Share by Application (2020-2025)
Table 31. Global Biologics CDMO Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Biologics CDMO Services Revenue Market Share by Application (2026-2031)
Table 33. North America Biologics CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Biologics CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Biologics CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Biologics CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Biologics CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Biologics CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Biologics CDMO Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Biologics CDMO Services Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Biologics CDMO Services Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Biologics CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Biologics CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biologics CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Biologics CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Biologics CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Biologics CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 48. Lonza Company Details
Table 49. Lonza Business Overview
Table 50. Lonza Biologics CDMO Services Product
Table 51. Lonza Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 52. Lonza Recent Development
Table 53. Catalent Company Details
Table 54. Catalent Business Overview
Table 55. Catalent Biologics CDMO Services Product
Table 56. Catalent Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 57. Catalent Recent Development
Table 58. Samsung Biologics Company Details
Table 59. Samsung Biologics Business Overview
Table 60. Samsung Biologics Biologics CDMO Services Product
Table 61. Samsung Biologics Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 62. Samsung Biologics Recent Development
Table 63. FUJIFILM Diosynth Biotechnologies Company Details
Table 64. FUJIFILM Diosynth Biotechnologies Business Overview
Table 65. FUJIFILM Diosynth Biotechnologies Biologics CDMO Services Product
Table 66. FUJIFILM Diosynth Biotechnologies Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 67. FUJIFILM Diosynth Biotechnologies Recent Development
Table 68. Boehringer Ingelheim Company Details
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Biologics CDMO Services Product
Table 71. Boehringer Ingelheim Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 72. Boehringer Ingelheim Recent Development
Table 73. WuXi Biologics Company Details
Table 74. WuXi Biologics Business Overview
Table 75. WuXi Biologics Biologics CDMO Services Product
Table 76. WuXi Biologics Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 77. WuXi Biologics Recent Development
Table 78. Recipharm Company Details
Table 79. Recipharm Business Overview
Table 80. Recipharm Biologics CDMO Services Product
Table 81. Recipharm Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 82. Recipharm Recent Development
Table 83. Thermo Fisher Scientific Company Details
Table 84. Thermo Fisher Scientific Business Overview
Table 85. Thermo Fisher Scientific Biologics CDMO Services Product
Table 86. Thermo Fisher Scientific Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 87. Thermo Fisher Scientific Recent Development
Table 88. AGC Biologics Company Details
Table 89. AGC Biologics Business Overview
Table 90. AGC Biologics Biologics CDMO Services Product
Table 91. AGC Biologics Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 92. AGC Biologics Recent Development
Table 93. Rentschler Biopharma Company Details
Table 94. Rentschler Biopharma Business Overview
Table 95. Rentschler Biopharma Biologics CDMO Services Product
Table 96. Rentschler Biopharma Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 97. Rentschler Biopharma Recent Development
Table 98. KBI Biopharma Company Details
Table 99. KBI Biopharma Business Overview
Table 100. KBI Biopharma Biologics CDMO Services Product
Table 101. KBI Biopharma Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 102. KBI Biopharma Recent Development
Table 103. Siegfried Company Details
Table 104. Siegfried Business Overview
Table 105. Siegfried Biologics CDMO Services Product
Table 106. Siegfried Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 107. Siegfried Recent Development
Table 108. Aenova Group Company Details
Table 109. Aenova Group Business Overview
Table 110. Aenova Group Biologics CDMO Services Product
Table 111. Aenova Group Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 112. Aenova Group Recent Development
Table 113. GenScript Company Details
Table 114. GenScript Business Overview
Table 115. GenScript Biologics CDMO Services Product
Table 116. GenScript Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 117. GenScript Recent Development
Table 118. ProBioGen Company Details
Table 119. ProBioGen Business Overview
Table 120. ProBioGen Biologics CDMO Services Product
Table 121. ProBioGen Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 122. ProBioGen Recent Development
Table 123. Northway Biotech Company Details
Table 124. Northway Biotech Business Overview
Table 125. Northway Biotech Biologics CDMO Services Product
Table 126. Northway Biotech Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 127. Northway Biotech Recent Development
Table 128. 3P Biopharmaceuticals Company Details
Table 129. 3P Biopharmaceuticals Business Overview
Table 130. 3P Biopharmaceuticals Biologics CDMO Services Product
Table 131. 3P Biopharmaceuticals Revenue in Biologics CDMO Services Business (2020-2025) & (US$ Million)
Table 132. 3P Biopharmaceuticals Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Biologics CDMO Services Picture
Figure 2. Global Biologics CDMO Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biologics CDMO Services Market Share by Type: 2024 VS 2031
Figure 4. Cell and Gene Therapies Features
Figure 5. Antibodies Features
Figure 6. Vaccines Features
Figure 7. Other Features
Figure 8. Global Biologics CDMO Services Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Biologics CDMO Services Market Share by Application: 2024 VS 2031
Figure 10. SMBs Case Studies
Figure 11. Large Companies Case Studies
Figure 12. Biologics CDMO Services Report Years Considered
Figure 13. Global Biologics CDMO Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Biologics CDMO Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Biologics CDMO Services Market Share by Region: 2024 VS 2031
Figure 16. Global Biologics CDMO Services Market Share by Players in 2024
Figure 17. Global Top Biologics CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics CDMO Services as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Biologics CDMO Services Revenue in 2024
Figure 19. North America Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Biologics CDMO Services Market Share by Country (2020-2031)
Figure 21. United States Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Biologics CDMO Services Market Share by Country (2020-2031)
Figure 25. Germany Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Biologics CDMO Services Market Share by Region (2020-2031)
Figure 33. China Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Biologics CDMO Services Market Share by Country (2020-2031)
Figure 41. Mexico Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Biologics CDMO Services Market Share by Country (2020-2031)
Figure 45. Turkey Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Biologics CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Lonza Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 49. Catalent Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 50. Samsung Biologics Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 51. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 52. Boehringer Ingelheim Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 53. WuXi Biologics Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 54. Recipharm Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 56. AGC Biologics Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 57. Rentschler Biopharma Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 58. KBI Biopharma Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 59. Siegfried Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 60. Aenova Group Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 61. GenScript Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 62. ProBioGen Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 63. Northway Biotech Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 64. 3P Biopharmaceuticals Revenue Growth Rate in Biologics CDMO Services Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global LED Light Housing Market Research Report 2025
Sep 24, 25
Global Side Emitting LED Strip Light Market Research Report 2025
Sep 24, 25
Global Medium and Low Voltage Unshielded Cable Market Research Report 2025
Sep 24, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232